Andhra Pharma unit tragedy: Extra leave could have saved woman engineer

Written By :  Ruchika Sharma
Published On 2024-08-27 06:00 GMT   |   Update On 2024-08-27 06:00 GMT

Amravati: The life of 22-year-old chemical engineer C. Harika, tragically lost in the recent industrial disaster in Anakapalli district, might have been saved if her employer had granted her an additional day of leave.

Harika, a young engineer from Kakinada, had recently returned home to celebrate Raksha Bandhan with her family. She sought an extra day off to attend a competitive examination on Wednesday. However, Escientia Advanced Sciences Pvt. Ltd. that manufactures intermediate chemicals and active pharmaceutical ingredients (API), denied her request for leave, local reports said.

Advertisement

As fate would have it, she came back to work only to become a victim of the powerful vapour cloud explosion at 2.20 pm on August 21 in the pharma unit in Atchutapuram.

She was one of the 17 people who perished, leaving her family in deep sorrow.

According to PTI, Harika had lost her father some years ago, and it's reported that her older brother had abandoned the family.

Despite these odds, she went on to study engineering, living with her mother and paternal grandmother.

Advertisement

Also Read:Navigated explosion, toxic fumes, darkness to save life: Survivor of AP pharma unit disaster

It's only 11 months ago that she had joined the pharma unit, and on Wednesday she had to rush back after Raksha Bandhan celebrations at home to meet her tragic end at the pharma plant.

Family members, neighbours and locals mourned her loss and were inconsolable on receiving her body on Thursday, following a post-mortem examination.

Meanwhile, the relatives of other deceased victims and injured workers vented their anger against the tight-lipped management of the company for not notifying them about the disaster.

“How can they not inform us? Did they hire these employees without interviews and taking their certificates? Where did the managing director go? Didn’t they take our (employees’) documents such as Aadhaar while joining?” thundered a frustrated woman while talking to a regional language news channel.

She questioned whether the management did not note the addresses of the employees while recruiting them and if it didn’t know how many employees were on shift and how many of them went missing.

Amid the many workers present at the plant during the disaster were a few lucky ones who managed to escape the horrifying accident, and K Satyanarayana (30) from Eluru is one of them.

“I ate lunch and sat in the quality control (QC) department on the first floor. Then we heard a big sound as if something collapsed. Immediately, I went down and saw several people injured. I saw one man with severed hands,” Satyanarayana told PTI.

Besides seeing several workers with bleeding injuries, he also noticed that all the equipment in the production laboratory located on the ground floor had fallen down and that the explosion had blown the second floor slab away.

Eager to escape, Satyanarayana, along with 11 others, tried to flee through the emergency exits but all of them were engulfed in fumes, prompting them to break a window on the third floor and raise an alarm to rescue them.

“After two hours, ladder vehicles were brought and all 11 of us were rescued around 4.30 pm. I am a QC executive, I do analysis. I joined the company only two months ago,” he said.

According to Satyanarayana, 400 people work in three shifts to run the unit 24x7.

The management of the plant located on a 40-acre campus in the Andhra Pradesh Industrial Infrastructure Corporation's multi-product SEZ at the Atchutapuram cluster is believed to be based in the US.

State Home Minister Vangalapudi Anitha complained that the management had ignored her calls when she went to take stock of the inferno.

Escientia Advanced Sciences commenced production in April 2019 with an investment of Rs 200 crore.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News